Table of ContentsREGULATION OF COAGULATION/DISSEMINATED INTRAVASCULAR COAGULATION REGULATION OF COAGULATION Introduction COAGULATION CASCADE COAGULATION INHIBITORS ANTITHROMBIN III - MECHANISM OF ACTION PROTEIN C ACTIVATION PROTEIN C - MECHANISM OF ACTION COAGULATION INHIBITORS ANTICOAGULANT PROTEIN DEFICIENCY Disease entities ANTICOAGULANT PROTEIN DEFICIENCY ACTIVATED PROTEIN C RESISTANCE ACTIVATED PROTEIN C RESISTANCE ACTIVATED PROTEIN C RESISTANCE PROTEIN C - MECHANISM OF ACTION PROTEIN C - MECHANISM OF ACTION HYPERCOAGULABLE STATES Acquired ACQUIRED HYPERCOAGULABLE STATES Mechanisms ANTITHROMBOTIC THERAPY HEPARIN THERAPY HEPARIN THERAPY Complications HEPARIN THERAPY Low Molecular Weight Heparin-Advantages HEPARIN Low Molecular Weight Heparin-Disadvantages LEPIRUDIN/ARGATROBAN COUMADIN (warfarin) Mechanism of Action THROMBOLYTIC THERAPY THROMBOLYTIC THERAPY Actions DIC ACUTE DIC DIC Plasminogen Activation FIBRINOGEN SPLIT PRODUCTS DEFIBRINATION Mechanisms DIC Testing (Acute) DIC Therapy LIVER DISEASE |
Author: David L. Diuguid |